Artivion Inc (AORT)

$46.31 -0.58 (-1.24%)
Market Cap 2.22B
Revenue (ttm) 388.54M
Net Income (ttm) -13.36M
EPS (ttm) N/A
PE Ratio 102.57
Forward PE 78.63
Profit Margin -3.44%
Debt to Equity Ratio 0.49
Volume 221,400
Avg Vol 389,652
Day's Range N/A - N/A
Shares Out 47.38M
Stochastic %K 40%
Beta 1.60
Analysts Strong Sell
Price Target $51.71

Company Profile

Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company provides BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac and preservation services; PhotoFix, a bovine pericardial patch; and aortic arch stent grafts, including E-vita Open NEO, E-vita Open Plus, ascyrus medical dissection stent hybrid prosthesis, E-vita THOR...

Industry: Medical Devices
Sector: Healthcare
Phone: 770 419 3355
Address:
1655 Roberts Boulevard NW, Kennesaw, United States
ComprehensionCaptain
ComprehensionCaptain Dec. 26 at 7:36 AM
$AORT Volatility reflects unresolved questions around how strategy converts into durable results. Strategic direction should avoid unnecessary detours. If milestones track on schedule, sentiment can re-rate faster than fundamentals. Future returns will be dictated by execution quality, not headlines.
0 · Reply
REDBEAR
REDBEAR Dec. 25 at 5:45 PM
$AORT masive b/o incoming.
0 · Reply
StockConsultant
StockConsultant Dec. 18 at 2:26 PM
$AORT Artivion stock, strong day, watch for a top of range breakout at https://stockconsultant.com/?AORT
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 12 at 4:57 PM
$AORT Current Stock Price: $45.15 Contracts to trade: $50 AORT Dec 19 2025 Call Entry: $0.24 Exit: $0.33 ROI: 35% Hold ~31 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
BillionerOfKing
BillionerOfKing Nov. 13 at 12:27 PM
$AORT Current Stock Price: $47.63 Contracts to trade: $50 AORT Nov 21 2025 Call Entry: $0.45 Exit: $0.82 ROI: 83% Hold ~23 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
smartkarma
smartkarma Nov. 10 at 3:11 AM
$AORT | Primer: Artivion (AORT US) - Nov 2025 "Artivion is a niche leader in aortic repair, demonstrating strong revenue growth driven by its key product families: On-X mechanical heart..." - αSK (Smartkarma) Read more: https://www.smartkarma.com/insights/primer-artivion-aort-us-nov-2025
0 · Reply
JarvisFlow
JarvisFlow Nov. 7 at 9:36 PM
Canaccord Genuity has updated their rating for Artivion ( $AORT ) to Buy with a price target of 51.
0 · Reply
StockConsultant
StockConsultant Nov. 7 at 2:28 PM
$AORT Artivion stock, nice continuation breakout at https://stockconsultant.com/?AORT
0 · Reply
JarvisFlow
JarvisFlow Nov. 7 at 1:42 PM
Citizens has adjusted their stance on Artivion ( $AORT ), setting the rating to Market Outperform with a target price of 47 → 53.
0 · Reply
JarvisFlow
JarvisFlow Nov. 7 at 10:01 AM
Needham has updated their rating for Artivion ( $AORT ) to Buy with a price target of 58.
0 · Reply
Latest News on AORT
Alger Weatherbie Specialized Growth Fund Q3 2025 Portfolio Update

Nov 12, 2025, 5:09 AM EST - 6 weeks ago

Alger Weatherbie Specialized Growth Fund Q3 2025 Portfolio Update

PI PLMR SMTC SPSC VRTX

Artivion, Inc. (AORT) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 11:46 PM EST - 7 weeks ago

Artivion, Inc. (AORT) Q3 2025 Earnings Call Transcript

Artivion Reports Third Quarter 2025 Financial Results

Nov 6, 2025, 4:05 PM EST - 7 weeks ago

Artivion Reports Third Quarter 2025 Financial Results

Artivion Announces Treatment of First Patient with Arcevo LSA in ARTIZEN Pivotal Trial

Nov 6, 2025, 8:00 AM EST - 7 weeks ago

Artivion Announces Treatment of First Patient with Arcevo LSA in ARTIZEN Pivotal Trial

Artivion to Participate in the Stifel 2025 Healthcare Conference

Oct 29, 2025, 4:10 PM EDT - 2 months ago

Artivion to Participate in the Stifel 2025 Healthcare Conference

Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2025 Financial Results

Oct 23, 2025, 4:10 PM EDT - 2 months ago

Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2025 Financial Results

Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE and AMDS PROTECT Trials at the 39th European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting

Oct 13, 2025, 8:00 AM EDT - 2 months ago

Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE and AMDS PROTECT Trials at the 39th European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting

Artivion, Inc. (AORT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Sep 10, 2025, 5:03 PM EDT - 3 months ago

Artivion, Inc. (AORT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Artivion to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference

Sep 5, 2025, 4:10 PM EDT - 4 months ago

Artivion to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference

Share Growth And Strong Clinical Results Continue To Support The Artivion Story

Sep 3, 2025, 7:47 AM EDT - 4 months ago

Share Growth And Strong Clinical Results Continue To Support The Artivion Story

Artivion, Inc. (AORT) Q2 2025 Earnings Call Transcript

Aug 8, 2025, 2:30 PM EDT - 5 months ago

Artivion, Inc. (AORT) Q2 2025 Earnings Call Transcript

Artivion Reports Second Quarter 2025 Financial Results

Aug 7, 2025, 4:05 PM EDT - 5 months ago

Artivion Reports Second Quarter 2025 Financial Results

Artivion to Participate in Upcoming Investor Conferences

Jul 30, 2025, 4:10 PM EDT - 5 months ago

Artivion to Participate in Upcoming Investor Conferences

Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2025 Financial Results

Jul 24, 2025, 4:10 PM EDT - 5 months ago

Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2025 Financial Results

Artivion Announces Closing of Transactions to Exchange $99.5 Million in Principal Amount of its 4.250% Convertible Notes Due 2025 for Common Stock

May 28, 2025, 5:51 PM EDT - 7 months ago

Artivion Announces Closing of Transactions to Exchange $99.5 Million in Principal Amount of its 4.250% Convertible Notes Due 2025 for Common Stock

Artivion Announces Agreements to Exchange $95 Million in Principal Amount of its 4.250% Convertible Notes Due 2025 for Common Stock

May 14, 2025, 4:01 PM EDT - 8 months ago

Artivion Announces Agreements to Exchange $95 Million in Principal Amount of its 4.250% Convertible Notes Due 2025 for Common Stock

Artivion, Inc. (AORT) Q1 2025 Earnings Call Transcript

May 5, 2025, 10:37 PM EDT - 8 months ago

Artivion, Inc. (AORT) Q1 2025 Earnings Call Transcript

Artivion Reports First Quarter 2025 Financial Results

May 5, 2025, 4:05 PM EDT - 8 months ago

Artivion Reports First Quarter 2025 Financial Results

Artivion Announces Presentation of New Clinical Data from NEXUS TRIOMPHE IDE Trial at the 105th American Association for Thoracic Surgery (AATS) Annual Meeting

May 5, 2025, 7:00 AM EDT - 8 months ago

Artivion Announces Presentation of New Clinical Data from NEXUS TRIOMPHE IDE Trial at the 105th American Association for Thoracic Surgery (AATS) Annual Meeting

Artivion Announces Release Date and Teleconference Call Details for First Quarter 2025 Financial Results

Apr 21, 2025, 4:10 PM EDT - 8 months ago

Artivion Announces Release Date and Teleconference Call Details for First Quarter 2025 Financial Results

Artivion to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference

Mar 4, 2025, 4:05 PM EST - 10 months ago

Artivion to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference

Artivion, Inc. (AORT) Q4 2024 Earnings Call Transcript

Feb 24, 2025, 11:00 PM EST - 10 months ago

Artivion, Inc. (AORT) Q4 2024 Earnings Call Transcript

Artivion Reports Fourth Quarter and Full Year 2024 Financial Results

Feb 24, 2025, 4:05 PM EST - 10 months ago

Artivion Reports Fourth Quarter and Full Year 2024 Financial Results

Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2024 Financial Results

Feb 10, 2025, 4:10 PM EST - 11 months ago

Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2024 Financial Results

Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE Trial at the 61st Society of Thoracic Surgery Annual Meeting

Jan 27, 2025, 8:00 AM EST - 11 months ago

Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE Trial at the 61st Society of Thoracic Surgery Annual Meeting

US medical device giant Artivion says hackers stole files during cybersecurity incident

Dec 9, 2024, 10:52 AM EST - 1 year ago

US medical device giant Artivion says hackers stole files during cybersecurity incident

Artivion Granted FDA Humanitarian Device Exemption for the AMDS Hybrid Prosthesis

Dec 9, 2024, 8:00 AM EST - 1 year ago

Artivion Granted FDA Humanitarian Device Exemption for the AMDS Hybrid Prosthesis

Artivion, Inc. (AORT) Q3 2024 Earnings Call Transcript

Nov 9, 2024, 12:02 PM EST - 1 year ago

Artivion, Inc. (AORT) Q3 2024 Earnings Call Transcript

Artivion Reports Third Quarter 2024 Financial Results

Nov 7, 2024, 4:05 PM EST - 1 year ago

Artivion Reports Third Quarter 2024 Financial Results

Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2024 Financial Results

Oct 24, 2024, 4:15 PM EDT - 1 year ago

Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2024 Financial Results

Artivion Announces Presentation of Late-Breaking Clinical Data at the 38th European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting

Oct 10, 2024, 4:10 PM EDT - 1 year ago

Artivion Announces Presentation of Late-Breaking Clinical Data at the 38th European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting

Artivion, Inc. (AORT) Q2 2024 Earnings Call Transcript

Aug 10, 2024, 2:45 PM EDT - 1 year ago

Artivion, Inc. (AORT) Q2 2024 Earnings Call Transcript

Artivion Reports Second Quarter 2024 Financial Results

Aug 8, 2024, 4:05 PM EDT - 1 year ago

Artivion Reports Second Quarter 2024 Financial Results

Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2024 Financial Results

Jul 25, 2024, 4:10 PM EDT - 1 year ago

Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2024 Financial Results

Artivion Amends Agreements with Endospan

Jul 1, 2024, 4:05 PM EDT - 1 year ago

Artivion Amends Agreements with Endospan

Data-Driven Growth Fuels More Upside For Overlooked Artivion

Jun 21, 2024, 5:01 PM EDT - 1 year ago

Data-Driven Growth Fuels More Upside For Overlooked Artivion

Artivion, Inc. (AORT) Q1 2024 Earnings Call Transcript

May 6, 2024, 10:47 PM EDT - 1 year ago

Artivion, Inc. (AORT) Q1 2024 Earnings Call Transcript

Artivion Reports First Quarter 2024 Financial Results

May 6, 2024, 4:05 PM EDT - 1 year ago

Artivion Reports First Quarter 2024 Financial Results

Artivion Announces Presentation of New Clinical Data for On-X Aortic Heart Valve and AMDS at the 104th American Association for Thoracic Surgery (AATS) Annual Meeting

Apr 29, 2024, 8:05 AM EDT - 1 year ago

Artivion Announces Presentation of New Clinical Data for On-X Aortic Heart Valve and AMDS at the 104th American Association for Thoracic Surgery (AATS) Annual Meeting

Artivion Announces Release Date and Teleconference Call Details for First Quarter 2024 Financial Results

Apr 22, 2024, 4:10 PM EDT - 1 year ago

Artivion Announces Release Date and Teleconference Call Details for First Quarter 2024 Financial Results

Artivion to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Apr 1, 2024, 4:10 PM EDT - 1 year ago

Artivion to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Artivion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference

Mar 6, 2024, 4:10 PM EST - 1 year ago

Artivion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference

Artivion, Inc. (AORT) Q4 2023 Earnings Call Transcript

Feb 15, 2024, 8:22 PM EST - 2 years ago

Artivion, Inc. (AORT) Q4 2023 Earnings Call Transcript

Artivion Reports Fourth Quarter and Full Year 2023 Financial Results

Feb 15, 2024, 4:05 PM EST - 2 years ago

Artivion Reports Fourth Quarter and Full Year 2023 Financial Results

Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2023 Financial Results

Feb 1, 2024, 4:10 PM EST - 2 years ago

Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2023 Financial Results

Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE Trial at the 60th Society of Thoracic Surgery Annual Meeting

Jan 29, 2024, 8:25 AM EST - 2 years ago

Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE Trial at the 60th Society of Thoracic Surgery Annual Meeting

Artivion Obtains $350 Million in Senior Secured Credit Facilities

Jan 18, 2024, 4:05 PM EST - 2 years ago

Artivion Obtains $350 Million in Senior Secured Credit Facilities

ARES

Artivion Appoints Lance A. Berry as Executive Vice President, Chief Financial Officer; Announces Retirement of D.

Dec 6, 2023, 4:15 PM EST - 2 years ago

Artivion Appoints Lance A. Berry as Executive Vice President, Chief Financial Officer; Announces Retirement of D.

Artivion Announces Completion of Enrollment in PERSEVERE Trial

Nov 9, 2023, 8:25 AM EST - 2 years ago

Artivion Announces Completion of Enrollment in PERSEVERE Trial

ComprehensionCaptain
ComprehensionCaptain Dec. 26 at 7:36 AM
$AORT Volatility reflects unresolved questions around how strategy converts into durable results. Strategic direction should avoid unnecessary detours. If milestones track on schedule, sentiment can re-rate faster than fundamentals. Future returns will be dictated by execution quality, not headlines.
0 · Reply
REDBEAR
REDBEAR Dec. 25 at 5:45 PM
$AORT masive b/o incoming.
0 · Reply
StockConsultant
StockConsultant Dec. 18 at 2:26 PM
$AORT Artivion stock, strong day, watch for a top of range breakout at https://stockconsultant.com/?AORT
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 12 at 4:57 PM
$AORT Current Stock Price: $45.15 Contracts to trade: $50 AORT Dec 19 2025 Call Entry: $0.24 Exit: $0.33 ROI: 35% Hold ~31 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
BillionerOfKing
BillionerOfKing Nov. 13 at 12:27 PM
$AORT Current Stock Price: $47.63 Contracts to trade: $50 AORT Nov 21 2025 Call Entry: $0.45 Exit: $0.82 ROI: 83% Hold ~23 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
smartkarma
smartkarma Nov. 10 at 3:11 AM
$AORT | Primer: Artivion (AORT US) - Nov 2025 "Artivion is a niche leader in aortic repair, demonstrating strong revenue growth driven by its key product families: On-X mechanical heart..." - αSK (Smartkarma) Read more: https://www.smartkarma.com/insights/primer-artivion-aort-us-nov-2025
0 · Reply
JarvisFlow
JarvisFlow Nov. 7 at 9:36 PM
Canaccord Genuity has updated their rating for Artivion ( $AORT ) to Buy with a price target of 51.
0 · Reply
StockConsultant
StockConsultant Nov. 7 at 2:28 PM
$AORT Artivion stock, nice continuation breakout at https://stockconsultant.com/?AORT
0 · Reply
JarvisFlow
JarvisFlow Nov. 7 at 1:42 PM
Citizens has adjusted their stance on Artivion ( $AORT ), setting the rating to Market Outperform with a target price of 47 → 53.
0 · Reply
JarvisFlow
JarvisFlow Nov. 7 at 10:01 AM
Needham has updated their rating for Artivion ( $AORT ) to Buy with a price target of 58.
0 · Reply
Wigglyick
Wigglyick Nov. 7 at 2:45 AM
$AORT another Algo-Doozio pick. Artivion , a med devise co that develope solutions addressing cardiac & vascular surgery challenges. Popped on August ER and based, breaking out again.
0 · Reply
Estimize
Estimize Nov. 6 at 4:00 PM
$AORT reports after the close, Estimize Consensus +0.01 EPS and +0.40M Revs compared to WS http://www.estimize.com/aort/fq3-2025?utm_conten
0 · Reply
Doozio
Doozio Oct. 18 at 3:34 PM
$AORT a say out of the tightness 🐒🍌🧠⏰♾️
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Oct. 9 at 2:44 PM
List 9/26/25 results $AORT $AOS $APD $APH 🔥 Cycle Trading Signal plugged into AI 🔥
0 · Reply
IN0V8
IN0V8 Sep. 29 at 6:07 PM
$AORT Canaccord Genuity raises target price to $50 from $41 Stifel raises target price to $46 from $40
0 · Reply
JarvisFlow
JarvisFlow Sep. 29 at 2:55 PM
Stifel updates rating for Artivion ( $AORT ) to Buy, target set at 40 → 46.
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 4 at 4:18 PM
$AORT Really good write-up that perfectly summarizes AORT's present situation. So if you want to bring your AORT knowledge up to date or just discover AORT, this is required reading. https://beyondspx.com/quote/AORT/artivion-s-aortic-ambition-a-growth-story-forged-by-innovation-and-strategic-deleveraging-nyse-aort#analysis
0 · Reply
FinJay
FinJay Aug. 24 at 3:10 AM
$AORT https://youtu.be/D8scJx747fE
0 · Reply
EntryRaider
EntryRaider Aug. 23 at 5:43 AM
$AORT Aortis Inc is a medical device company with innovative technology but unproven commercial adoption
0 · Reply
Albino_Trader123
Albino_Trader123 Aug. 22 at 6:18 PM
$AORT Very clean chart. nice fundamentals and picture perfect breakout and nobody watching
0 · Reply
JarvisFlow
JarvisFlow Aug. 22 at 11:30 AM
Needham has updated their rating for Artivion ( $AORT ) to Buy with a price target of 50.
0 · Reply
stockanalysis_
stockanalysis_ Aug. 19 at 10:36 PM
After Hours Losers: $MEDP $AORT $LZB $JHX $GTLS Save this screener here: https://stockanalysis.com/markets/afterhours/losers/ Discount code SAVEONTRADING to pick up Stock Analysis for just $5.91/m.
0 · Reply